INVESTORS OVERVIEW
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. AN2 has a pipeline of boron-based compounds in development for Chagas disease, NTM, and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
![AN2 Tower](/system/files-encrypted/nasdaq_kms/inline-images/4-27-22-AN2-Tower.jpg)